Related Experiment Videos
[Immunosuppressive therapy of myocarditis?]
H P Schultheiss1, U Kühl, I Janda
1Medizinische Klinik Heinrich-Heine-Universität Düsseldorf.
Herz
|April 1, 1992
Summary
Autoimmune mechanisms are implicated in postmyocardial cardiomyopathy. Immunohistochemical methods improve myocarditis diagnosis, aiding understanding of immune roles in dilated cardiomyopathy.
Area of Science:
- Cardiology
- Immunology
- Pathology
Background:
- Autoimmune mechanisms are increasingly recognized in the pathogenesis of postmyocardial cardiomyopathy.
- Viral infections may trigger or induce these autoimmunological responses.
- Immunosuppressive therapy is being explored to prevent myocarditis progression to dilated cardiomyopathy.
Purpose of the Study:
- To discuss the role of immunosuppressive therapy in managing myocarditis and preventing dilated cardiomyopathy.
- To highlight the diagnostic limitations of traditional histological examination of endomyocardial biopsies.
- To introduce and evaluate new immunohistochemical methods for improved myocarditis diagnosis.
Main Methods:
- Histological examination of endomyocardial biopsies using Dallas criteria for acute myocarditis.
- Application of immunohistochemical techniques with monoclonal antibodies (CD3, CD4, CD8, MHC-class-I, class-II) for cell identification and characterization.
- Review of existing studies on immunosuppressive therapy for histologically-proven myocarditis.
Main Results:
- Traditional histology faces limitations, including interobserver variability and difficulty differentiating cell types.
- Immunohistochemistry significantly enhances the specificity and sensitivity of diagnosing lymphocytic infiltrates in the myocardium.
- New methods provide deeper insights into the immunological status of the myocardium.
Conclusions:
- Immunohistological methods offer a more accurate diagnosis of myocarditis and better understanding of its immune pathogenesis.
- Established immunological criteria complement histological parameters for improved diagnostic accuracy.
- Current studies on immunosuppressive therapy for myocarditis are limited by non-randomized designs, small sample sizes, and lack of standardized protocols.